Johnson & Johnson
Johnson & Johnson
Johnson & Johnson, with $20 billion in sales, is the worlds largest and most comprehensive manufacturer of health care products serving the consumer, pharmaceutical and professional markets founded in 1886. Johnson & Johnson has approximately 89,300 employees. Its common stock is a component of the Dow Jones Industrial Average and the company is listed among the Fortune 500. Johnson & Johnson is known for its corporate responsibility and consistently ranks at the top of Interactive National Corporate Reputation Survey. The corporations headquarters is located in New Brunswick, New Jersey, United States. Its consumer division is located in Skillman, New Jersey. The corporation includes some 230 subsidiary companies with operations in over 50 countries. Its products are sold in over 175 countries. Johnson & Johnsons brands include numerous household names of medications and first aid supplies. Among its well-known consumer products are the Band-Aid Brand line of bandages, Tylenol medications, JOHNSONS Baby products, Neutrogena skin and beauty products, Clean & Clear facial wash and Acuvue contact lenses.
Robert Wood Johnson, inspired by a speech by antisepsis advocate Joseph Lister, joined brothers James Wood Johnson and Edward Mead Johnson to create a line of ready-to-use surgical dressings in 1885. The company produced its first products in 1886 and incorporated in 1887. Robert Wood Johnson served as the first president of the company. He worked to improve sanitary practices in the nineteenth century, and lent his name to a hospital in New Brunswick, New Jersey. Upon his death in 1910, he was succeeded in the presidency by his brother James Wood Johnson until 1932, and then by his son, Robert Wood Johnson II.
The Company operates in three segments: Consumer, Pharmaceutical, and Medical Devices and Diagnostics. Sales of the Companys two largest products, RISPERDAL/RISPERDAL CONSTA and PROCRIT/EPREX, accounted for approximately 8% and 6% of Johnson & Johnsons total revenues, respectively, during the year ended December 31, 2006. In May 2006, ETHICON, Inc., a Johnson & Johnson company, acquired Vascular Control Systems, Inc., which is focused on developing medical devices to treat fibroids and to control bleeding in obstetric and gynecologic applications. On December 20, 2006, the Company completed the acquisition of the Consumer Healthcare business of Pfizer Inc. In February 2007, the